Dr. Castro on High Risk CLL and Richter's Tran... - CLL Support

CLL Support

23,139 members39,744 posts

Dr. Castro on High Risk CLL and Richter's Transformation

bkoffman profile image
bkoffmanCLL CURE Hero
0 Replies

Friends,

Today on the cllsociety.org, we share Dr. Januario Castro's lecture from the Patient Empowerment and Education Meeting held at UCSD in April 2015 about using targeted therapies to treat high-risk CLL, specifically Richter's transformation, plus a description of a new clinical trial that he, Dr. Kipps and Dr. Choi are running out of UCSD. Please take a look here to see the article and video cllsociety.org/2015/11/targ... of his talk.

The countdown is on! This week I'll be taking my every 10 year family practice board exams (I really should be studying and am doing the absolute minimum CLL related work), next week is Thanksgiving and the follow week is the American Society of Hematology Annual Meeting in Orlando. No rest for the weary! We're finalizing our schedule to attend the most exciting presentations about CLL, viewing the CLL posters and interviewing CLL experts from around the world. These are very exciting times for patients and those researching the most effective treatments for CLL in the goal towards a cure.

REGISTER NOW: If you live in the Los Angeles area, please consider attending a post-ASH patient education forum and CLL Society LA support group launch in conjunction with City of Hope. Dr. Tanya Siddiqi will be presenting on the latest data on Diagnosis and Frontline Treatment and Dr. Steven Rosen will present on Relapsed Disease and Novel Therapies. The meeting is scheduled for Saturday, Dec. 12, 2015. You can access the flier at cllsociety.org/docs/COH%20P... and pre-registration is requested. We look forward to meeting you there.

Stay strong.

We are all this together

Brian Koffman

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

Dr. Kanti Rai on the Future of CLL Therapy

Friends, This week we have posted an interview with one and only Dr. Kanti Rai when he sat down to...

ASCO 2016: Dr. Susan O’Brien where she discusses frontline data on Acalabrutinib in CLL

We are 8 weeks out from the 2016 annual meeting of the American Society of Hematology and realize...

My Take on 3 Interesting Papers on CLL from ASCO 2015

Friends, This week on CLL Society (http://cllsociety.org) in our 2015 conference coverage...

Prevalence and Economic Burden of Chronic Lymphocytic Leukemia (CLL) in the Era of Oral Targeted Therapies

This has been a banner year for developments in the treatment of CLL. In this last week of 2015 on...

Part 2 of ASH Interview with Dr. Sharman, a patient meeting in Seattle and off to iwCLL later tonight

Friends, This week on the CLL Society website, in our Conference coverage section, we share the...